Anzeige
Mehr »
Montag, 01.09.2025 - Börsentäglich über 12.000 News
Blockbuster-Potenzial und Übernahmefantasie: Hier entsteht das nächste Big Pharma-Ziel!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1KAGC | ISIN: DK0060448595 | Ticker-Symbol: CBHD
Tradegate
01.09.25 | 13:18
83,08 Euro
+0,65 % +0,54
1-Jahres-Chart
COLOPLAST A/S Chart 1 Jahr
5-Tage-Chart
COLOPLAST A/S 5-Tage-Chart
RealtimeGeldBriefZeit
83,4283,4814:15
83,4283,4814:15

Aktuelle News zur COLOPLAST Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
22.08.Coloplast stock price target raised to DKK710 from DKK700 at RBC29
19.08.Coloplast Finance B.V.: Coloplast A/S - Interim Financial Report, 9M 2024/258
19.08.Coloplast A/S - Updated presenters list for Capital Markets Day on 2 September 20255
19.08.Coloplast reports solid Q3 with 6.6% organic sales growth40
19.08.Coloplast meldet solides Q3-Ergebnis und hält an Prognose fest87
19.08.Coloplast Q3 Profit Down, But Revenue Edges Up521COPENHAGEN (dpa-AFX) - Coloplast A/S (COLOb.CO) Tuesday reported profit before tax of DKK 1.342 billion for the third quarter, 18% lower than DKK 1.631 billion in the same quarter a year ago...
► Artikel lesen
19.08.Coloplast A/S Non-GAAP EPS of DKK 3.86, revenue of DKK 6.96B; reaffirms FY outlook28
19.08.Coloplast A/S - Announcement no. 05/2025 - Coloplast announces changes to Executive Leadership Team204Coloplast announces changes to Executive Leadership Team The Coloplast Board of Directors are making changes to the Executive Leadership Team (ELT) to support the successful execution of the new Coloplast...
► Artikel lesen
COLOPLAST Aktie jetzt für 0€ handeln
19.08.Coloplast A/S - Interim Financial Report, 9M 2024/251542024/25 Interim financial results, 9M 2024/25 1 October 2024 - 30 June 2025 Coloplast delivered organic growth of 7% and an EBIT margin1 of 28% in Q3. Reported revenue in DKK grew 1% with negative...
► Artikel lesen
03.06.Coloplast A/S - Invitation to Coloplast's Capital Markets Day on 2 September 202554
20.05.Coloplast senkt Prognose - Konzernchef muss gehen294
15.05.HSBC cuts Coloplast stock rating, lowers price target to DKK67062
09.05.RBC Capital cuts Coloplast stock rating, lowers price target49
08.05.Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons41
07.05.Barclays cuts Coloplast stock rating, lowers price target87
06.05.Coloplast Finance B.V.: Coloplast A/S - Announcement no. 04/2025 - Interim Financial Report, H1 2024/2539
06.05.Coloplast A/S - Announcement no. 04/2025 - Interim Financial Report, H1 2024/25925Interim financial results, H1 2024/25 1 October 2024 - 31 March 2025 Coloplast delivered 6% organic growth in Q2, impacted by the product recall in Interventional Urology and a softer quarter in...
► Artikel lesen
05.05.Coloplast A/S CEO Kristian Villumsen steps down as of today825Coloplast CEO Kristian Villumsen steps down from his CEO position as of today. The Board of Directors has asked Lars Rasmussen to step in as interim CEO. As the company is entering into a new strategy...
► Artikel lesen
05.05.Coloplast stock rating cut, target slashed by Deutsche Bank60
01.05.Coloplast A/S Revised guidance for FY 2024/25709Coloplast revises financial guidance for FY 2024/25 and pre-announces H1 2024/25 key financial figures Coloplast revises the guidance on organic growth and EBIT margin before special items for FY...
► Artikel lesen
Weiter >>
32 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,3,3